Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Omar Aguejouf"'
Autor:
Omar Aguejouf, Christian Doutremepuich, Philippe Belon, Vanessa Desplat, Francisco X. Eizayaga
Publikováno v:
Homeopathy : the journal of the Faculty of Homeopathy. 108(3)
Background Aspirin is the oldest and possibly the most widely used pharmacologically active substance still used in allopathic medicine. Its effect on fever and inflammation has paved the way to its anti-thrombotic effect. Dilutions of aspirin have b
Autor:
Omar Aguejouf, Christian Doutremepuich, Dominique Duprat, Vanessa Desplat, Francisco X. Eizayaga
Publikováno v:
Thrombosis
Acetyl salicylic acid (ASA) is widely used in clinical practice. Previous studies done in rats showed unexpected thrombotic potencies of this drug used at ultra-low doses. This review is the first report in which the effects of a wide range of ASA co
Publikováno v:
Cardiovascular & Hematological Disorders-Drug Targets. 10:103-110
Aspirin administration decreases the risk of vascular ischemic problems. However, aspirin withdrawal may temporarily increase this risk. Previous studies reported that high dilutions of aspirin might cause a pro-thrombotic effect. This paper studies
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 36:40-44
Background: While aspirin is the drug most often used to prevent cardiovascular complications, its discontinuation induces an increased risk of acute coronary syndrome and ischemic stroke in some patients. Objectives: We hypothesized that infinitesim
Autor:
Philippe Belon, Vanessa Desplat, Omar Aguejouf, Francisco X. Eizayaga, Christian Doutremepuich
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 35:357-363
In our previous study, we demonstrated the effect of ultralow-dose aspirin (ULDA) on platelet activity and bleeding in rats with portal hypertension (PHT) produced by portal vein ligation (PVL). This paper reports modifications in this effect caused
Publikováno v:
Thrombosis Research. 108:245-248
An animal model was developed to study arterial thrombosis and determine if animals infected with Helicobacter pylori behave differently after induction of direct damage to blood vessels. Twenty-one C56/BL6 mice inoculated with the “Sydney strain
Publikováno v:
Thrombosis Research. 100:317-323
Aspirin has a well established role in the prevention of arterial thrombosis. Discussion on the efficacy and safety of aspirin in the treatment and prophylaxis of thrombosis has become an important issue. In fact, hemorrhage complications are often a
Publikováno v:
Thrombosis Research. 100:167-177
Controversy still exists about the pro- or antithrombotic side effects of contrast media used in daily medical practice. Recent reports have shown that various contrast media, including ionic compounds, have deleterious prothrombotic actions. A new e
Autor:
Christian Doutremepuich, Emmanuelle Belougne-Malfatti, Philippe Belon, Omar Aguejouf, F. Doutremepuich
Publikováno v:
Thrombosis Research. 90:215-221
The antithrombotic effect of high dose acetylsalicylic acid is well known, and recently, in vitro studies hinted the potent thrombotic effect of ultra-low dose of acetylsalicylic acid (
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis. 4:118-125
Heparin is still the major anticoagulant of choice during CPB, but it may cause thrombocytopenia and severe bleeding in patients. In light of these complications, the devel opment of new anticoagulant drugs seemed to be necessary for these patients.